#Ozempic #GLP1 #Semaglutide #WeightLossJourney #ObesityMedicine
Most Ozempic and Mounjaro side effects are just uncomfortable — but a few can land you in the ER. In this video, Dr. Mohammed Paika (board-certified internal medicine + obesity medicine physician, 15+ years as a hospitalist) breaks down which GLP-1 side effects are genuinely dangerous, who's at higher risk, and the exact red-flag symptoms you should never wait out.
What's covered:
Why GLP-1 side effects happen (the mechanism in plain terms)
Nausea/vomiting: normal vs. red flag
Dehydration and acute kidney injury
DKA risk for diabetics on GLP-1s
Gallbladder disease and pancreatitis
Gastroparesis, explained without the internet hype
The thyroid cancer warning — what the label actually means
Muscle loss: the side effect no one talks about (and how to prevent it)
Mood changes and when to get help
A full red-flag quick-reference recap
This video is for education, not medical advice — always talk to your own prescriber about your specific situation.
Want the full system for nutrition, protein targets, training, and side-effect management on GLP-1 medications? Join the GLP-1 Masterclass at https://drmohammedpaika.com
If this helped, subscribe for the next video on structuring protein and training week-by-week on these medications.
If you or someone you know is struggling with thoughts of self-harm, call or text 988 (Suicide & Crisis Lifeline).
GLP-1 Weight Loss Masterclass - https://www.drmohammedpaika.com
Dr. Paika Podcast - https://drmohammedpaika.transistor.fm/
Amazon Kindle - https://www.amazon.it/GLP-1-Masterclass-Physicians-Preservation-Metabolic-ebook/dp/B0GZBR8MC4
Timestamps
0:00 Intro
0:49 Who I Am
2:58 Why GLP-1 Side Effects Happen
3:57 Nausea & Vomiting: Where It Usually Starts
5:05 Dehydration & Acute Kidney Injury
7:41 Starvation Ketosis & DKA Risk
9:37 Quick Note: GLP-1 Masterclass
10:17 Gallbladder Disease & Pancreatitis
12:35 Gastroparesis: The Internet-Famous One
14:01 The Thyroid Cancer Myth
15:55 Muscle Wasting: The One I See Most Often
19:13 Mood Changes & Depression
21:01 Who Is At Higher Risk: The Summary
21:59 The Red Flags: Quick Recap
22:43 Close & Next Steps
References:
FDA Prescribing Information — Ozempic (semaglutide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf)
FDA Prescribing Information — Mounjaro (tirzepatide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s039lbl.pdf)
FDA Prescribing Information — Zepbound (tirzepatide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf)
(Wegovy shares the same active ingredient, semaglutide, and labeling basis as Ozempic.)
Wilding JPH, et al. STEP 1 body composition sub-study — DEXA data on fat vs. lean mass loss: [J Endocr Soc](https://academic.oup.com/jes/article/5/Supplement_1/A16/6240360)
Look M, et al. SURMOUNT-1 body composition sub-study — lean mass findings on tirzepatide: [Diabetes Obes Metab, 2025](https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16275)
Bjerre Knudsen L, et al. Endocrinology 2010;151(4):1473-1486 — the rodent thyroid C-cell study behind the boxed warning: [Oxford Academic](https://academic.oup.com/endo/article/151/4/1473/2456651)
👨⚕️ ABOUT DR. MOHAMMED K. PAIKA
Board-Certified in Internal Medicine and Obesity Medicine
Certified Personal Trainer & Nutrition Coach
Helping people understand metabolism, hormones, and sustainable health through evidence-based medicine.
👍 Like
💬 Comment
📌 Share
🔔 Subscribe for more honest conversations about obesity, metabolism, hormones, and real-world health solutions
⚕️ MEDICAL & EDUCATIONAL DISCLAIMER
This channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.
Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.
Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.
Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.
Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.